Condition: OSA · Sponsor: Apnimed
This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obstructive Sleep Apnea.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Sleep Disorders Center of Alabama | Birmingham, Alabama, United States | — |
| Chandler Clinical Trials | Chandler, Arizona, United States | — |
| Preferred Research Partners, Inc. | Little Rock, Arkansas, United States | — |
| Orange County Research Institute | Anaheim, California, United States | — |
| Marvel Clinical Research, LLC | Huntington Beach, California, United States | — |
| CenExel CNS | Los Alamitos, California, United States | — |
| Santa Monica Clinical Trials | Los Angeles, California, United States | — |
| Empire Clinical Research | Pomona, California, United States | — |
| Pacific Research Network | San Diego, California, United States | — |
| SDS Clinical Trials Inc. | Santa Ana, California, United States | — |
| Alpine Clinical Research Center | Boulder, Colorado, United States | — |
| Mountain View Clinical Research, Inc. | Denver, Colorado, United States | — |
+ 52 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.